News

Monday, October 7, 2013

​University of Pittsburgh Cancer Institute and Roswell Park Cancer Institute Awarded $11 Million to Fight Ovarian Cancer>

The five-year grant award comes through the NCI’s Specialized Program of Research Excellence (SPORE), and will fund three clinical trials evaluating newly developed immunotherapies and an epidemiological study examining strategies to reduce risk in women

Monday, October 7, 2013

New Pitt Center for Pharmaceutical Policy and Prescribing Opens With Talk on Health Care Reform Effects on Medication Use>

The Center for Pharmaceutical Policy and Prescribing (CP3) will foster multidisciplinary collaboration in its mission to inform public policy regarding pharmaceuticals and improve patient and physician decision-making.

Tuesday, October 1, 2013

‘Science 2013—Convergence’ Celebrates Exceptional Researchers, Innovative Technology>

Science 2013 – Convergence highlights the region’s academic and research strengths in science, engineering, medicine and computation. It also includes presentations by some of Pittsburgh’s leading researchers.

Monday, September 30, 2013

When Cells ‘Eat’ Their Own Power Plants; Pitt Scientists Solve Mystery of Basic Cellular Process>

A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health

Monday, September 30, 2013

Next Generation Sequencing Test Developed at UPMC Improves Detection of Thyroid Cancer, Reduces Unnecessary Surgeries >

The new test, called ThyroSeq, was designed and developed by Dr. Nikiforov and his team and uses a technique called next-generation sequencing.

Friday, September 27, 2013

McGowan Institute Will Co-Direct $75 Million Second Phase of National Effort to Aid Wounded Warriors>

The Armed Forces Institute for Regenerative Medicine (AFIRM) will continue its efforts to apply the latest in tissue engineering and other regenerative medicine techniques to the treatment of battlefield injuries in a $75 million, five-year second phase.

Thursday, September 19, 2013

Three National Leaders in Sickle Cell Treatment, Research Join UPMC>

Three national leaders in the research and treatment of sickle cell disease have joined the UPMC Adult Sickle Cell Disease Program, marking a major commitment by UPMC to improving the care of patients with this devastating genetic disease.

Wednesday, September 18, 2013

Genomics Innovator Dietrich Stephan Named Chair of Pitt Public Health Department of Human Genetics>

Dietrich A. Stephan, Ph.D., has been named chair of the Department of Human Genetics at the University of Pittsburgh Graduate School of Public Health.

Wednesday, September 18, 2013

Research on Computer Modeling for Emergency Preparedness Featured in Special Journal Issue>

Cutting-edge research on computational modeling of public health emergencies and simulations of the potential response by Pitt's School of Public Health, is featured in a special issue of the Journal of Public Health Management and Practice.

Monday, September 16, 2013

Unusual Combination Therapy Shows Promise for Preventing Prostate Cancer, UPCI Researchers Find>

Combining a compound from broccoli with an antimalarial drug prevents prostate cancer in mice, University of Pittsburgh Cancer Institute (UPCI) researchers discovered.